FORTE accrues first 1000 participants for highly anticipated colorectal cancer prevention trial

  • Post author:
  • Post category:uncategorized

FORTE (NRG-CC005) is a highly anticipated colorectal cancer prevention trial led by NRG Oncology examining surveillance colonoscopy intervals in participants who have non-advanced polyps.